AGEs-RAGE mediated up-regulation of connexin43 in activated human microglial CHME-5 cells

Neurochemistry International

Volumn 60, Issue 6, 2012, Pages 640-651

  Shaikh, Shamim B ^a   Uy, Benedict ^a   Perera, Amali ^a   Nicholson, Louise F B ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

AGEs; CHME 5; Connexin43; Human microglia; RAGE; TNFRII

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CONNEXIN 43; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ARTICLE; CELL ACTIVATION; CYTOKINE PRODUCTION; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INFLAMMATION; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ANIMALS; CELL LINE, TRANSFORMED; CONNEXIN 43; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MICROGLIA; RECEPTORS, IMMUNOLOGIC; RODENTIA; SPECIES SPECIFICITY; UP-REGULATION;

RODENTIA;

EID: 84860468574     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2012.02.023     Document Type: Article

References (72)

1. B.M. Altevogt, and D.L. Paul Four classes of intercellular channels between glial cells in the CNS J. Neurosci. 24 2004 4313 4323
2. C.L. Atanassov, C.D. Muller, and S. Dumont Effect of ammonia on endocytosis and cytokine production by immortalized human microglia and astroglia cells Neurochem. Int. 27 1995 417 424
3. Becker, D.L., Green, C.R., 2002. Gap-junction mediated interactions between cells. In: Cell-Cell Interactions (T.P, F., ed): Oxford University Press, pp 47-70.
4. K. Bigl, F. Gaunitz, and A. Schmitt Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation J. Neural Transm.: Gen. Sect. 115 2008 1545 1556
5. C.F. Brosnan, E. Scemes, and D.C. Spray Cytokine regulation of gap-junction connectivity: an open-and-shut case or changing partners at the Nexus? Am. J. Pathol. 158 2001 1565 1569
6. C. Colton, S. Wilt, and D. Gilbert Species differences in the generation of reactive oxygen species by microglia Mol. Chem. Neuropathol. 28 1996 15 20
7. E. Dalfo, and I. Ferrer Alpha-synuclein binding to rab3a in multiple system atrophy Neurosci. Lett. 380 2005 170 175
8. E. Dalfo, M. Portero-Otin, and V. Ayala Evidence of oxidative stress in the neocortex in incidental Lewy body disease J. Neuropathol. Exp. Neurol. 64 2005 816 830
9. F.M.-P. de Gannes, M. Merle, and P. Canioni Metabolic and cellular characterization of immortalized human microglial cells under heat stress Neurochem. Int. 33 1998 61 73
10. R. Dermietzel, Y. Gao, and E. Scemes Connexin43 null mice reveal that astrocytes express multiple connexins Brain Res. Brain Res. Rev. 32 2000 45 56
11. J.M. Dopp, T.A. Sarafian, and F.M. Spinella Expression of the p75 TNF receptor is linked to TNF-induced NFkappaB translocation and oxyradical neutralization in glial cells Neurochem. Res. 27 2002 1535 1542
12. M. Dragunow The adult human brain in preclinical drug development Nat. Rev. Drug Discovery 7 2008 659 666
13. S. Dukic-Stefanovic, J. Gasic-Milenkovic, and W. Deuther-Conrad Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs) J. Neurochem. 87 2003 44 55
14. C. Eskes, L. Juillerat-Jeanneret, and G. Leuba Involvement of microglia-neuron interactions in the tumor necrosis factor-alpha release, microglial activation, and neurodegeneration induced by trimethyltin J. Neurosci. Res. 71 2003 583 590
15. E.A. Eugenin, M.C. Branes, and J.W. Berman TNF-{alpha} plus IFN-{gamma} induce connexin43 expression and formation of gap-junctions between human monocytes/macrophages that enhance physiological responses J. Immunol. 170 2003 1320 1328
16. E.A. Eugenin, D. Eckardt, and M. Theis Microglia at brain stab wounds express connexin 43 and in vitro form functional gap-junctions after treatment with interferon- and tumor necrosis factor-alpha Proc. Natl. Acad. Sci. U. S. A. 98 2001 4190 4195
17. E.A. Eugenin, H.E. Gonzalez, and H.A. Sanchez Inflammatory conditions induce gap junctional communication between rat Kupffer cells both in vivo and in vitro Cell. Immunol. 247 2007 103 110
18. C.G. Fonseca, C.R. Green, and L.F. Nicholson Upregulation in astrocytic connexin 43 gap-junction levels may exacerbate generalized seizures in mesial temporal lobe epilepsy Brain Res. 929 2002 105 116
19. H.-M. Gao, J. Jiang, and B. Wilson Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease J. Neurochem. 81 2002 1285 1297
20. S. Garg, M. Md Syed, and T. Kielian Staphylococcus aureus-derived peptidoglycan induces Cx43 expression and functional gap-junction intercellular communication in microglia J. Neurochem. 95 2005 475 483
21. J.V. Gefter, A.L. Shaufl, and M.P. Fink Comparison of distinct protein isoforms of the receptor for advanced glycation end-products expressed in murine tissues and cell lines Cell Tissue Res. 337 2009 79 89
22. M.B. Graeber, K. Bise, and P. Mehraein CR3/43, a marker for activated human microglia: application to diagnostic neuropathology Neuropathol. Appl. Neurobiol. 20 1994 406 408
23. J. He, and F.T. Crews Increased MCP-1 and microglia in various regions of the human alcoholic brain Exp. Neurol. 210 2008 349 358
24. Y. Horikoshi, and A. Sasaki Human GLUT5 immunolabeling is useful for evaluating microglial status in neuropathological study using paraffin sections Acta Neuropathol. 105 2003 157 162
25. N. Janabi, S. Peudenier, and B. Heron Establishment of human microglial cell lines after transfection of primary cultures of embryonic microglial cells with the SV40 large T antigen Neurosci. Lett. 195 1995 105 108
26. J. Kawanokuchi, T. Mizuno, and H. Takeuchi Production of interferon-gamma by microglia Mult. scler. (Houndmills, Basingstoke, England) 12 2006 558 564
27. T. Kielian Glial connexins and gap-junctions in CNS inflammation and disease J. Neurochem. 106 2008 1000 1016
28. B. Kuhla, C. Loske, and S. Garcia De Arriba Differential effects of "Advanced glycation endproducts" and beta-amyloid peptide on glucose utilization and ATP levels in the neuronal cell line SH-SY5Y J. Neural Transm.: Gen. Sect. 111 2004 427 439
29. L.J. Lawson, V.H. Perry, and P. Dri Heterogeneity in the heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain Neurosci. Lett. 39 1990 151 170
30. L.F. Lue, D.G. Walker, and L. Brachova Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism Exp. Neurol. 171 2001 29 45
31. L.F. Lue, S.D. Yan, and D.M. Stern Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease Curr. Drug Targets CNS Neurol. Disord. 4 2005 249 266
32. F. Macouillard-Poulletier de Gannes, N. Leducq, and P. Diolez Mitochondrial impairment and recovery after heat shock treatment in a human microglial cell line Neurochem. Int. 36 2000 233 241
33. E.G. McGeer, and P.L. McGeer The role of the immune system in neurodegenerative disorders Mov. Disord. 12 1997 855 858
34. P.L. McGeer, S. Itagaki, and B.E. Boyes Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains Neurology 38 1988 1285 1291
35. G. Munch, J. Gasic-Milenkovic, and S. Dukic-Stefanovic Microglial activation induces cell death, inhibits neurite outgrowth and causes neurite retraction of differentiated neuroblastoma cells Exp. Brain Res. 150 2003 1 8
36. G. Munch, M. Gerlach, and J. Sian Advanced glycation end products in neurodegeneration: more than early markers of oxidative stress? Ann. Neurol. 44 1998 S85 88
37. G. Munch, H.J. Luth, and A. Wong Crosslinking of alpha-synuclein by advanced glycation endproducts-an early pathophysiological step in Lewy body formation? J. Chem. Neuroanat. 20 2000 253 257
38. A. Nagai, E. Nakagawa, and K. Hatori Generation and characterization of immortalized human microglial cell lines: expression of cytokines and chemokines Neurobiol. Dis. 8 2001 1057 1068
39. T. Nagatsu, and M. Sawada Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects J. Neural Transm.: Gen. Sect. Suppl. 2007 113 120
40. A. Neumann, R. Schinzel, and D. Palm High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-[kappa]B activation and cytokine expression FEBS Lett. 453 1999 283 287
41. S.J. O'Carroll, M. Alkadhi, and L.F. Nicholson Connexin 43 mimetic peptides reduce swelling, astrogliosis, and neuronal cell death after spinal cord injury Cell Commun. Adhes. 15 2008 27 42
42. M. Osawa, Y. Yamamoto, and S. Munesue De-N-glycosylation or G82S mutation of RAGE sensitizes its interaction with advanced glycation endproducts Biochim. Biophys. Acta 1770 2007 1468 1474
43. M. Pahujaa, M. Anikin, and G.S. Goldberg Phosphorylation of connexin43 induced by Src: regulation of gap junctional communication between transformed cells Exp. Cell Res. 313 2007 4083 4090
44. S.J. Park, T. Kleffmann, and P.A. Hessian The G82S polymorphism promotes glycosylation of the receptor for advanced glycation end products (RAGE) at Asn81: a comparison of wild-type RAGE with the G82S polymorphic variant J. Biol. Chem 2011
45. M. Peppa, J. Uribarri, and H. Vlassara Glucose, advanced glycation end products, and diabetes complications: what is new and what works Clin. Diabetes 21 2003 186 187
46. S. Peudenier, C. Hery, and L. Montagnier Human microglial cells: characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection Ann. Neurol. 29 1991 152 161
47. R. Ramasamy, S.J. Vannucci, and S.S. Yan Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation Glycobiology 15 2005 16R 28R
48. J.E. Rash, T. Yasumura, and K.G. Davidson Identification of cells expressing Cx43, Cx30, Cx26, Cx32 and Cx36 in gap-junctions of rat brain and spinal cord Cell Commun. Adhes. 8 2001 315 320
49. J. Rogers, J. Luber-Narod, and S.D. Styren Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease Neurobiol. Aging 9 1988 339 349
50. J.C. Saez, A.D. Martinez, and M.C. Branes Regulation of gap-junctions by protein phosphorylation Braz. J. Med. Biol. Res. 31 1998 593 600
51. A. Sasaki, H. Yamaguchi, and Y. Horikoshi Expression of glucose transporter 5 by microglia in human gliomas Neuropathol. Appl. Neurobiol. 30 2004 447 455
52. A. Sasaki, H. Yamaguchi, and A. Ogawa Microglial activation in early stages of amyloid β protein deposition Acta Neuropathol. 94 1997 316 322
53. A.M. Schmidt, S.D. Yan, and S.F. Yan The biology of the receptor for advanced glycation end products and its ligands Biochim. Biophys. Acta 1498 2000 99 111
54. A. Schmitt, K. Bigl, and I. Meiners Induction of reactive oxygen species and cell survival in the presence of advanced glycation end products and similar structures Biochim. Biophys. Acta, Mol. Cell Res. 1763 2006 927 936
55. A. Schmitt, I. Meiners, and J. Schmitt Two analytical methods to study the interaction of AGEs with cell surface proteins J. Biochem. Biophys. Methods 65 2005 121 136
56. A. Schmitt, J. Schmitt, and G. Munch Characterization of advanced glycation end products for biochemical studies: side chain modifications and fluorescence characteristics Anal. Biochem. 338 2005 201 215
57. S. Shaikh, and L.F. Nicholson Optimization of the Tet-On system for inducible expression of RAGE J. Biomol. Tech. 17 2006 283 292
58. S. Shaikh, and L.F. Nicholson AGEs induce in vitro cross-linking of alpha-synuclein and accelerate the process of intracellular inclusion body formation J. Neurosci. Res. 86 2008 2071 2082
59. S.B. Shaikh, and L.F. Nicholson Effects of chronic low dose rotenone treatment on human microglial cells Mol. Neurodegener. 4 2009 55
60. S. Shavali, C. Combs, and M. Ebadi Reactive macrophages increase oxidative stress and alpha-synuclein nitration during death of dopaminergic neuronal cells in co-culture: relevance to Parkinson's disease Neurochem. Res. 31 2006 85 94
61. T.B. Sherer, R. Betarbet, and J.H. Kim Selective microglial activation in the rat rotenone model of Parkinson's disease Neurosci. Lett. 341 2003 87 90
62. J. Solan, and P. Lampe Key connexin 43 phosphorylation events regulate the gap-junction life cycle J. Membr. Biol. 217 2007 35 41
63. H. Takeuchi, S. Jin, and J. Wang Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner J. Biol. Chem. 281 2006 21362 21368
64. C. Thery, and M. Mallat Influence of interleukin-1 and tumor necrosis factor alpha on the growth of microglial cells in primary cultures of mouse cerebral cortex: involvement of colony-stimulating factor 1 Neurosci. Lett. 150 1993 195 199
65. J.V. Valencia, S.C. Weldon, and D. Quinn Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics Anal. Biochem. 324 2004 68 78
66. W. Vandamme, K. Braet, and L. Cabooter Tumour necrosis factor alpha inhibits purinergic calcium signalling in blood-brain barrier endothelial cells J. Neurochem. 88 2004 411 421
67. A.L. Wang, A.C. Yu, and Q.H. He AGEs mediated expression and secretion of TNF alpha in rat retinal microglia Exp. Eye Res. 84 2007 905 913
68. C.Y. Wang, H.J. Liu, and H.J. Chen AGE-BSA down-regulates endothelial connexin43 gap-junctions BMC Cell Biol. 12 2011 19
69. A. Wong, H.J. Luth, and W. Deuther-Conrad Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease Brain Res. 920 2001 32 40
70. S.D. Yan, X. Chen, and J. Fu RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease Nature 382 1996 685 691
71. S.D. Yan, D. Stern, and M.D. Kane RAGE-Abeta interactions in the pathophysiology of Alzheimer's disease Restor. Neurol. Neurosci. 12 1998 167 173
72. S.F. Yan, R. Ramasamy, and Y. Naka Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond Circ. Res. 93 2003 1159 1169